PT0253

· PAQ Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PT0253, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors [Phase 1]